Valuation: Retractable Technologies, Inc.

Market Cap 17.39M 15.53M 14.32M 13.01M 24.41M 1.65B 24.79M 173M 67.97M 863M 65.29M 63.89M 2.73B P/E 2024
-1.7x
P/E 2025 -1.8x
Enterprise Value -18.37M -16.4M -15.13M -13.75M -25.79M -1.74B -26.19M -182M -71.8M -912M -68.97M -67.49M -2.89B EV / Sales 2024
-0.69x
EV / Sales 2025 -0.33x
Free-Float
35.63%
Yield 2024 *
-
Yield 2025 -
1 day+0.69%
1 week-0.46%
Current month-15.30%
1 month-15.78%
3 months-13.94%
6 months-10.79%
Current year-24.19%
1 week 0.58
Extreme 0.576
0.6
1 month 0.58
Extreme 0.576
0.73
Current year 0.58
Extreme 0.576
0.79
1 year 0.58
Extreme 0.576
1.01
3 years 0.56
Extreme 0.5649
1.34
5 years 0.56
Extreme 0.5649
10.19
10 years 0.54
Extreme 0.54
21.5
Manager TitleAgeSince
Chief Executive Officer 75 08/05/1994
Director of Finance/CFO 57 31/03/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 75 08/05/1994
Director/Board Member 78 21/03/2005
Director/Board Member 57 31/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
14/11/25 Buy

Chief Executive Officer

5,731 0.0191%
11/11/25 Buy

Chief Executive Officer

100 0.0003%
05/11/25 Buy

Chief Executive Officer

7,500 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-0.46%-40.28%-51.63% 17.39M
+1.58%-2.38%-20.13%+6.69% 174B
+2.87%+4.83%-20.85%+16.63% 114B
+2.77%+0.32%-0.15%+32.28% 114B
+1.93%+19.13%-43.11%+7.04% 89.64B
-0.18%-0.32%+2.87%+80.23% 64.96B
-0.47%+3.86%+15.10%+80.50% 56.09B
+1.69%+2.40%+5.48%-22.47% 52.94B
+2.18%+3.61%-10.55%+32.55% 43.6B
+3.43%+4.93%-5.06%-10.80% 32.77B
Average +1.68%+3.52%-11.67%+17.10% 74.2B
Weighted average by Cap. +1.85%+3.58%-12.22%+22.87%

Financials

2024 2025
Net sales 33.05M 29.5M 27.22M 24.73M 46.39M 3.13B 47.1M 328M 129M 1.64B 124M 121M 5.2B 38.27M 34.16M 31.51M 28.63M 53.71M 3.62B 54.53M 380M 150M 1.9B 144M 141M 6.02B
Net income -11.89M -10.61M -9.79M -8.89M -16.68M -1.13B -16.94M -118M -46.45M -590M -44.62M -43.66M -1.87B -12.57M -11.22M -10.35M -9.4M -17.64M -1.19B -17.91M -125M -49.1M -624M -47.16M -46.15M -1.98B
Net Debt -43.33M -38.68M -35.68M -32.42M -60.82M -4.1B -61.75M -430M -169M -2.15B -163M -159M -6.81B -35.77M -31.93M -29.45M -26.76M -50.2M -3.39B -50.97M -355M -140M -1.78B -134M -131M -5.62B
Projected Income Statement - Annual - Retractable Technologies, Inc.
Logo Retractable Technologies, Inc.
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Employees
198
Date Price Change Volume
22/10/26 US$0.5810 0.00% 8,997
21/10/26 US$0.5810 -0.02% 33,509
20/10/26 US$0.5811 +0.54% 13,707
19/10/26 US$0.5780 +0.33% 13,209
16/10/26 US$0.5761 -2.02% 27,567